$ARWR
ARROWHEAD PHARMACEUTICALS, INC.

2021 Q3 Form 10-K Financial Statement

#000156459021057888 Filed on November 22, 2021

View on sec.gov

Income Statement

Concept 2021 Q3 2021 2020 Q3
Revenue $38.28M $138.3M $7.633M
YoY Change 401.56% 57.16% -82.37%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $37.39M $80.08M $14.11M
YoY Change 164.96% 54.89% 37.39%
% of Gross Profit
Research & Development $63.28M $199.0M $41.86M
YoY Change 51.17% 54.4% 78.97%
% of Gross Profit
Depreciation & Amortization $2.504M $6.600M $1.700M
YoY Change 47.29% 57.14% 70.0%
% of Gross Profit
Operating Expenses $103.2M $287.3M $57.75M
YoY Change 78.64% 58.61% 71.62%
Operating Profit -$149.0M -$50.12M
YoY Change 59.98% -620.01%
Interest Expense $1.148M $6.120M $2.270M
YoY Change -49.43% -33.41% 1.34%
% of Operating Profit
Other Income/Expense, Net $363.0K $2.070M -$580.0K
YoY Change -162.59% -75.95%
Pretax Income -$63.37M -$140.8M -$48.43M
YoY Change 30.85% 66.58% -507.66%
Income Tax $2.000K $2.000K $0.00
% Of Pretax Income
Net Earnings -$63.37M -$140.8M -$48.43M
YoY Change 30.85% 66.58% -513.78%
Net Earnings / Revenue -165.54% -101.85% -634.53%
Basic Earnings Per Share -$1.36 -$0.48
Diluted Earnings Per Share -$607.8K -$1.358M -$0.48
COMMON SHARES
Basic Shares Outstanding 103.7M shares
Diluted Shares Outstanding 103.7M

Balance Sheet

Concept 2021 Q3 2021 2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $311.1M $367.8M $228.6M
YoY Change 36.11% 16.57% -11.64%
Cash & Equivalents $184.4M $184.4M $143.6M
Short-Term Investments $126.7M $183.4M $85.00M
Other Short-Term Assets $2.191M $6.553M $1.782M
YoY Change 22.95% 7.43% -30.48%
Inventory
Prepaid Expenses $4.362M $4.251M
Receivables $10.26M $10.26M $846.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $384.6M $384.6M $322.4M
YoY Change 19.3% 19.29% 21.54%
LONG-TERM ASSETS
Property, Plant & Equipment $48.68M $66.02M $30.88M
YoY Change 57.62% 40.47% 33.02%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $245.6M $245.6M $137.5M
YoY Change 78.61% 78.61% 211.09%
Other Assets $272.0K $272.0K $264.0K
YoY Change 3.03% -9.33% 83.15%
Total Long-Term Assets $325.6M $325.6M $200.1M
YoY Change 62.67% 62.69% 136.57%
TOTAL ASSETS
Total Short-Term Assets $384.6M $384.6M $322.4M
Total Long-Term Assets $325.6M $325.6M $200.1M
Total Assets $710.1M $710.1M $522.5M
YoY Change 35.91% 35.91% 49.35%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $9.457M $9.457M $6.829M
YoY Change 38.48% 39.07% -10.73%
Accrued Expenses $14.00M $26.02M $5.389M
YoY Change 159.81% 79.48% -17.15%
Deferred Revenue $111.1M $19.29M
YoY Change 475.68% -75.19%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $146.5M $146.5M $40.68M
YoY Change 260.2% 260.04% -58.09%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $154.8M $154.8M $20.00M
YoY Change 673.95% 673.95% 129.89%
Total Long-Term Liabilities $154.8M $154.8M $20.04M
YoY Change 672.29% 673.95% 129.36%
TOTAL LIABILITIES
Total Short-Term Liabilities $146.5M $146.5M $40.68M
Total Long-Term Liabilities $154.8M $154.8M $20.04M
Total Liabilities $301.3M $301.3M $60.73M
YoY Change 396.21% 396.42% -42.61%
SHAREHOLDERS EQUITY
Retained Earnings -$644.7M -$503.8M
YoY Change 27.95% 20.17%
Common Stock $1.054B $965.6M
YoY Change 9.11%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $408.8M $408.8M $461.8M
YoY Change
Total Liabilities & Shareholders Equity $710.1M $710.1M $522.5M
YoY Change 35.91% 35.91% 49.35%

Cashflow Statement

Concept 2021 Q3 2021 2020 Q3
OPERATING ACTIVITIES
Net Income -$63.37M -$140.8M -$48.43M
YoY Change 30.85% 66.58% -513.78%
Depreciation, Depletion And Amortization $2.504M $6.600M $1.700M
YoY Change 47.29% 57.14% 70.0%
Cash From Operating Activities -$24.12M $171.2M -$10.90M
YoY Change 121.26% -279.48% -178.99%
INVESTING ACTIVITIES
Capital Expenditures -$8.199M -$23.57M -$1.900M
YoY Change 331.53% -297.19% -75.64%
Acquisitions
YoY Change
Other Investing Activities -$110.0M -$118.1M -$64.00M
YoY Change 71.95% -48.38% -359.11%
Cash From Investing Activities -$118.2M -$141.7M -$65.90M
YoY Change 79.43% -41.16% -489.94%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 815.0K 11.31M 1.000M
YoY Change -18.5% -95.62% -47.37%
NET CHANGE
Cash From Operating Activities -24.12M 171.2M -10.90M
Cash From Investing Activities -118.2M -141.7M -65.90M
Cash From Financing Activities 815.0K 11.31M 1.000M
Net Change In Cash -141.5M 40.85M -75.80M
YoY Change 86.74% -152.23% -332.52%
FREE CASH FLOW
Cash From Operating Activities -$24.12M $171.2M -$10.90M
Capital Expenditures -$8.199M -$23.57M -$1.900M
Free Cash Flow -$15.92M $194.8M -$9.000M
YoY Change 76.87% -281.45% -141.67%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y6M21D
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y6M29D
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.004
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.004
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0150
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y3M
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y3M
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y3M
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.011
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.018
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.031
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.862
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.900
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.904
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.920
CY2021 dei Document Annual Report
DocumentAnnualReport
true
CY2021 dei Document Transition Report
DocumentTransitionReport
false
CY2021 dei Entity File Number
EntityFileNumber
001-38042
CY2021 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2021 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-0408024
CY2021 dei Entity Address Address Line1
EntityAddressAddressLine1
177 E. Colorado Blvd
CY2021 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 700
CY2021 dei Entity Address City Or Town
EntityAddressCityOrTown
Pasadena
CY2021 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2021 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
91105
CY2021 dei City Area Code
CityAreaCode
626
CY2021 dei Local Phone Number
LocalPhoneNumber
304-3400
CY2021 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2070000
CY2020 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-583000
CY2019 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-370000
CY2021 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2021Q1 dei Entity Public Float
EntityPublicFloat
5900000000
CY2021Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
104525708
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
143583000
CY2020Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
846000
CY2020Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
4251000
CY2020Q3 us-gaap Other Assets Current
OtherAssetsCurrent
1782000
CY2021Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
126728000
CY2020Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
85020000
CY2021Q3 us-gaap Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
56627000
CY2020Q3 us-gaap Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
86890000
CY2021Q3 us-gaap Assets Current
AssetsCurrent
384597000
CY2020Q3 us-gaap Assets Current
AssetsCurrent
322372000
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
48675000
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
30881000
CY2021Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
13663000
CY2020Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
15363000
CY2021Q3 us-gaap Held To Maturity Securities Noncurrent
HeldToMaturitySecuritiesNoncurrent
245595000
CY2020Q3 us-gaap Held To Maturity Securities Noncurrent
HeldToMaturitySecuritiesNoncurrent
137487000
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
17346000
CY2020Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
16137000
CY2021Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
272000
CY2020Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
264000
CY2021Q3 us-gaap Assets
Assets
710148000
CY2020Q3 us-gaap Assets
Assets
522504000
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
9457000
CY2020Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
6829000
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
14001000
CY2020Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5389000
CY2021Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
9773000
CY2020Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
8061000
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2250000
CY2020Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1095000
CY2021Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
111055000
CY2020Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
19291000
CY2020Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
17000
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
146536000
CY2020Q3 us-gaap Liabilities Current
LiabilitiesCurrent
40682000
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
23295000
CY2020Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
20043000
CY2021Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
131495000
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
11305000
CY2020 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
7469000
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
154790000
CY2020Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
20043000
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
145000000
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
104327000
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
104327000
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
197000
CY2020Q3 us-gaap Common Stock Value
CommonStockValue
195000
CY2021Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1053386000
CY2020Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
965410000
CY2021Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-69000
CY2020Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
18000
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-644692000
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-503844000
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
408822000
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
710148000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2000
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
103745000
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-87000
CY2020 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
410000
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-140935000
CY2020 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-84143000
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
12393000
CY2019 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
8276000
CY2019 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
60521000
CY2021 us-gaap Profit Loss
ProfitLoss
-140848000
CY2020 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
250479000
CY2020 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
410000
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
76673000
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
11305000
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-87000
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
408822000
CY2020 us-gaap Profit Loss
ProfitLoss
-84553000
CY2019 us-gaap Profit Loss
ProfitLoss
67975000
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2628000
CY2020 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-821000
CY2019 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
4844000
CY2021 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
9522000
CY2020 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1989000
CY2019 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
2450000
CY2021 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
223258000
CY2021 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
240703000
CY2020 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
278964000
CY2019 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
90266000
CY2021 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
122592000
CY2020 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
50138000
CY2019 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
54521000
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-47746000
CY2019 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
8275000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
143583000
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
221804000
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
66382000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
40851000
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-78221000
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
191671000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
143583000
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
221804000
CY2018Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
30133000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
184434000
CY2019 us-gaap Interest Paid Net
InterestPaidNet
27000
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-2000
CY2020 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
103000
CY2019 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-302000
CY2021Q3 us-gaap Marketable Securities
MarketableSecurities
126700000
CY2021Q3 us-gaap Held To Maturity Securities Noncurrent
HeldToMaturitySecuritiesNoncurrent
245600000
CY2021 arwr Increase Decrease In Cash And Investments
IncreaseDecreaseInCashAndInvestments
160400000
CY2021Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
2400000
CY2020Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
1800000
CY2021 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Concentration of Credit Risk—The Company maintains several bank accounts primarily at two financial institutions for its operations. These accounts are insured by the Federal Deposit Insurance Corporation (FDIC) for up to $250,000 per institution. Management believes the Company is not exposed to significant credit risk due to the financial position of the depository institutions in which these deposits are held. </p>
CY2020Q3 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
0
CY2021Q3 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
0
CY2021 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0
CY2020 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0
CY2019 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
4748958
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
17300000
CY2021Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
25500000
CY2021Q3 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
1661000
CY2021Q3 arwr Research Equipment Gross
ResearchEquipmentGross
27500000
CY2020Q3 arwr Research Equipment Gross
ResearchEquipmentGross
20654000
CY2021Q3 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
509000
CY2021Q3 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
41869000
CY2021Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
71539000
CY2021Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
22864000
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
48675000
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
30881000
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6600000
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4200000
CY2019 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2700000
CY2021Q3 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
302222000
CY2021Q3 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Gain
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
1954000
CY2021Q3 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Loss
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
103000
CY2020Q3 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
224377000
CY2020Q3 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Gain
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
6164000
CY2020Q3 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Loss
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
79000
CY2020Q3 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
230462000
CY2021Q3 us-gaap Equity Securities Fv Ni Cost
EquitySecuritiesFvNiCost
125000000
CY2021Q3 arwr Equity Securities Fv Ni Accumulated Gross Realized Gains Loss Before Tax
EquitySecuritiesFvNiAccumulatedGrossRealizedGainsLossBeforeTax
2481000
CY2021Q3 arwr Equity Securities Fvni Accumulated Gross Unrealized Gain Before Tax
EquitySecuritiesFVNIAccumulatedGrossUnrealizedGainBeforeTax
135000
CY2021Q3 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
126728000
CY2020Q3 us-gaap Equity Securities Fv Ni Cost
EquitySecuritiesFvNiCost
85000000
CY2020Q3 arwr Equity Securities Fv Ni Accumulated Gross Realized Gains Loss Before Tax
EquitySecuritiesFvNiAccumulatedGrossRealizedGainsLossBeforeTax
95000
CY2020Q3 arwr Equity Securities Fvni Accumulated Gross Unrealized Loss Before Tax
EquitySecuritiesFVNIAccumulatedGrossUnrealizedLossBeforeTax
75000
CY2020Q3 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
85020000
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1700000
CY2020 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1700000
CY2019 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1700000
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
1700000
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1700000
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1700000
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1700000
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
1700000
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
5200000
CY2020Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
15363000
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1700000
CY2021Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
13663000
CY2021Q3 us-gaap Capital Units Authorized
CapitalUnitsAuthorized
150000000
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
145000000
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
104326672
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
149501055
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
5100000
CY2020 us-gaap Operating Lease Cost
OperatingLeaseCost
2400000
CY2019 us-gaap Operating Lease Cost
OperatingLeaseCost
1300000
CY2021 us-gaap Variable Lease Cost
VariableLeaseCost
800000
CY2020 us-gaap Variable Lease Cost
VariableLeaseCost
800000
CY2019 us-gaap Variable Lease Cost
VariableLeaseCost
500000
CY2021 us-gaap Short Term Lease Cost
ShortTermLeaseCost
0
CY2020 us-gaap Short Term Lease Cost
ShortTermLeaseCost
0
CY2019 us-gaap Short Term Lease Cost
ShortTermLeaseCost
0
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
4708000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
4786000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
4621000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
4749000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
5050000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
13200000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
37114000
CY2021Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
11569000
CY2021Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
25545000
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
3100000
CY2020 us-gaap Operating Lease Payments
OperatingLeasePayments
1800000
CY2019 us-gaap Operating Lease Payments
OperatingLeasePayments
1300000
CY2021Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P8Y
CY2021Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.085
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4539403
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
16.67
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
186000
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
65.57
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
217820
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
40.12
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1051344
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
10.75
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3456239
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
19.60
CY2021Q3 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
6360000
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
13.80
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2510091
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
12.23
CY2021Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
126302948
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Description
ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription
At vesting, each outstanding RSU will be exchanged for one share of the Company’s Common Stock. RSU awards generally vest subject to the satisfaction of service requirements or the satisfaction of both service requirements and achievement of certain performance targets.
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.15
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
48.64
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
36.35
CY2021Q3 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
0
CY2020Q3 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
0
CY2021Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
2371000
CY2020Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
2086000
CY2021Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
22454000
CY2020Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
10937000
CY2021Q3 arwr Deferred Tax Assets In Process Research And Development Cost
DeferredTaxAssetsInProcessResearchAndDevelopmentCost
324000
CY2020Q3 arwr Deferred Tax Assets In Process Research And Development Cost
DeferredTaxAssetsInProcessResearchAndDevelopmentCost
625000
CY2021Q3 us-gaap Deferred Tax Assets Tax Credit Carryforwards Alternative Minimum Tax
DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax
179000
CY2020Q3 us-gaap Deferred Tax Assets Tax Credit Carryforwards Alternative Minimum Tax
DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax
179000
CY2021Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
185431000
CY2020Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
151007000
CY2021Q3 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
3562000
CY2020Q3 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
2818000
CY2020Q3 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
1702000
CY2021Q3 arwr Deferred Tax Assets Right Of Use Assets Or Lease Liabilities
DeferredTaxAssetsRightOfUseAssetsOrLeaseLiabilities
1938000
CY2020Q3 arwr Deferred Tax Assets Right Of Use Assets Or Lease Liabilities
DeferredTaxAssetsRightOfUseAssetsOrLeaseLiabilities
1016000
CY2020Q3 us-gaap Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
710000
CY2021Q3 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
216259000
CY2020Q3 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
171080000
CY2021Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
194255000
CY2020Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
156604000
CY2020Q3 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
2547000
CY2021Q3 arwr Deferred Tax Liabilities State Taxes
DeferredTaxLiabilitiesStateTaxes
15644000
CY2020Q3 arwr Deferred Tax Liabilities State Taxes
DeferredTaxLiabilitiesStateTaxes
11929000
CY2021Q3 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
22004000
CY2020Q3 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
14476000
CY2021Q3 arwr Percentage Of Valuation Allowance
PercentageOfValuationAllowance
1
CY2021Q3 arwr Federal Net Operating Loss Carry Forward
FederalNetOperatingLossCarryForward
569000000.0
CY2021Q3 arwr State Net Operating Loss Carry Forwards
StateNetOperatingLossCarryForwards
626500000
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
2000
CY2020 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
2000
CY2021 us-gaap State And Local Income Tax Expense Benefit Continuing Operations
StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
2000
CY2020 us-gaap State And Local Income Tax Expense Benefit Continuing Operations
StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
2000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2000
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.070
CY2020 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.070
CY2021 arwr Effective Income Tax Rate Reconciliation Deductions Stock Compensation Percent
EffectiveIncomeTaxRateReconciliationDeductionsStockCompensationPercent
-0.013
CY2020 arwr Effective Income Tax Rate Reconciliation Deductions Stock Compensation Percent
EffectiveIncomeTaxRateReconciliationDeductionsStockCompensationPercent
-0.133
CY2021 arwr Effective Income Tax Rate Reconciliation Mark To Market Adjustments
EffectiveIncomeTaxRateReconciliationMarkToMarketAdjustments
0.000
CY2020 arwr Effective Income Tax Rate Reconciliation Mark To Market Adjustments
EffectiveIncomeTaxRateReconciliationMarkToMarketAdjustments
0.000
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.293
CY2020 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.433
CY2021 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.000
CY2020 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.020
CY2021 arwr Effective Income Tax Rate Reconciliation True Up On Deferred Tax Rate
EffectiveIncomeTaxRateReconciliationTrueUpOnDeferredTaxRate
0.000
CY2020 arwr Effective Income Tax Rate Reconciliation True Up On Deferred Tax Rate
EffectiveIncomeTaxRateReconciliationTrueUpOnDeferredTaxRate
0.000
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.000
CY2020 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.000
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000
CY2021Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2020Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2021 us-gaap Unrecognized Tax Benefits Income Tax Penalties Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense
0
CY2020 us-gaap Unrecognized Tax Benefits Income Tax Penalties Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense
0
CY2021 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Expense
UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense
0
CY2020 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Expense
UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense
0
CY2021 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
1300000
CY2020 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
900000
CY2019 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
500000

Files In Submission

Name View Source Status
0001564590-21-057888-index-headers.html Edgar Link pending
0001564590-21-057888-index.html Edgar Link pending
0001564590-21-057888.txt Edgar Link pending
0001564590-21-057888-xbrl.zip Edgar Link pending
arwr-10k_20210930.htm Edgar Link pending
arwr-10k_20210930_htm.xml Edgar Link completed
arwr-20210930.xsd Edgar Link pending
arwr-20210930_cal.xml Edgar Link unprocessable
arwr-20210930_def.xml Edgar Link unprocessable
arwr-20210930_lab.xml Edgar Link unprocessable
arwr-20210930_pre.xml Edgar Link unprocessable
arwr-ex211_11.htm Edgar Link pending
arwr-ex231_12.htm Edgar Link pending
arwr-ex311_6.htm Edgar Link pending
arwr-ex312_15.htm Edgar Link pending
arwr-ex321_10.htm Edgar Link pending
arwr-ex322_14.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gfmvgbft1fv3000001.jpg Edgar Link pending
gfmvgbft1fv3000002.jpg Edgar Link pending
gfmvgbft1fv3000003.jpg Edgar Link pending
gfmvgbft1fv3000004.jpg Edgar Link pending
gfmvgbft1fv3000005.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending